My research interest revolves around precision medicine, particularly looking at pharmacogenomics and epigenetics' influence on drug therapy. In addition, I am also involved in clinical pharmacy-based studies. During my Ph.D., I am involved in research that used methylation array and pyrosequencing to identify and measure the methylation levels of genes that are involved in cisplatin resistance among pediatric germ cell tumor patients. Among the works that I had and am currently involved in include:

1. CYP2C19 polymorphisms and their association with clopidogrel response
2. HLA gene polymorphism and their association with antiepileptic-induced cutaneous adverse drug reaction
3. Gene polymorphism association with carbamazepine response
4. Gene polymorphism association with gastrointestinal side effects of metformin
5. Animal studies looking into gene methylation and depression.
6. Pharmacist education program in oral chemotherapy monitoring
7. Acceptance towards pharmacists as an immunizer
8. Statin effect on glucose control and cognitive dysfunction

Ongoing Research

1. CYP2C19 polymorphisms and their association with clopidogrel response
2. HLA gene polymorphism and their association with antiepileptic-induced cutaneous adverse drug reaction
3. Gene polymorphism association with carbamazepine response
4. Gene polymorphism association with gastrointestinal side effects of metformin

1. Genetic polymorphism analysis
2. DNA methylation analysis

1. ORWA ALBITAR* , SABARIAH NOOR BINTI HARUN , RAMA BALLOUZE , DZULAZRI BIN MOHAMED NOOR , SITI MAISHARAH BINTI SHEIKH GHADZI*, 2021, Atime-dissociated pharmacokinetics pharmacodynamics model of cyclosporine amongMalaysan renal transplant recipients., Therapeutic Drug Monitoring
2. ALI FADHEL AHMED* , NUR FADHLINA BINTI MUSA , DZUL AZRI BINMOHAMED NOOR , NUR AIZATI ATHIRAH BINTI DAUD*, 2021, Genetic Determinantsin HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-InducedSevere Cutaneous Adverse Reactions, Journal of Personalized Medicine, 383
3. MOHAMMED AHMED AKKAIF* , N.A.A.D , A. Sha'aban , MEI LI NG , MUHAMADALI SK ABDUL KADER , D.A.M.N , BAHARUDIN IBRAHIM*, 2021, The Role of GeneticPolymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Populationwith Coronary Heart Disease (CHD), Molecules, 26/7:, 1-18
4. DZUL AZRI BIN MOHAMED NOOR, 2021, Prevalence of pharmacogenomicvariants in 100 pharmacogenes among Southeast Asian populations under thecollaboration of the Southeast Asian Pharmacogenomics Research Network(SEAPharm), Human Genome Variation
5. MOHAMMED AHMED AKKAIF* , A. Sha'aban* , N.A.A.D , ISMAEEL YUNUSA , MEILI NG , MUHAMAD ALI SK ABDUL KADER , D.A.M.N , BAHARUDIN IBRAHIM*, 2021,Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelorand Clopidogrel? A Systematic Review and Meta-Analysis of Randomized ControlledTrials, Journal of Cardiovascular Development and Disease, 8/23:, 1-12
6. MOHAMMED AHMED AKKAIF* , N.A.A.D , ABUBAKAR SHA'ABAN , MEI LI NG ,MUHAMAD ALI SK ABDUL KADER , D.A.M.N , BAHARUDIN IBRAHIM*, 2021, The Roleof Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an AsianPopulation with Coronary Heart Disease (CHD), Molecules, 26/7:, 1-18
7. NUR AIZATI ATHIRAH BINTI DAUD* , CHEW BENG HOONG* , G SARAVANAGOVINDASAMY* , NUR FADHLINA BINTI MUSA , DZUL AZRI BIN MOHAMED NOOR,2021, Diagnostic Tests and Genetic Screening for Antiepileptic-Induced SevereCutaneous Adverse Reactions (SCAR) in Resource Limited Setting, Malaysian Journal of Human Genetics, Vol.2 (1):, 18-35
8. AKKAIF, MOHAMMED & SHA'ABAN, ABUBAKAR & DAUD, NUR AIZATI ATHIRAH &
   NOOR, DZUL & MUSA, NURFADHLINA & KADER, MUHAMMAD ALI & IBRAHIM, BAHARUDIN.
   2022. Fast and more affordable CYP2C19 LOF testing to personalized of clopidogrel therapy.
   European Heart Journal
9. AKKAIF, MOHAMMED & BITAR, AHMAD & AL-KAIF, LAITH & DAUD, NUR AIZATI
   ATHIRAH & SHA'ABAN, ABUBAKAR & NOOR, DZUL & ABD. AZIZ, FATIMATUZZAHRA &
   CESARO, ARTURO & KADER, MUHAMAD ALI & JAHANGIR, MOHAMED & KHAW, CHEE &
   IBRAHIM, BAHARUDIN. (2022). The Management of Myocardial Injury Related to SARS-CoV-2
   Pneumonia. Journal of Cardiovascular Development and Disease. 9. 307.
10. BASHIR, MUHAMMAD & ABDUL AZIZ, NUR HIDAYAH KAZ & NOOR, DZUL. (2022). Influence of Polygonum minus Aqueous Extract on Monoamine Oxidase-A Transcriptional
    Activators KLF-11 and SIRT1 Levels in the Hippocampus of Stress-induced Depressed Mice.
    International Journal of Pharmaceutical Investigation. 12. 375-379.
11. BASHIR, MUHAMMAD & ABDUL AZIZ, NUR HIDAYAH KAZ & NOOR, DZUL. (2022). Antidepressant-Like Effects of Polygonum minus Aqueous Extract in Chronic Ultra-Mild Stress-
    Induced Depressive Mice Model. Behavioral Sciences. 12. 196
12. ABUBAKAR U, SUBRAMANIAM L, AYINLA A, AMBALI MN, MOHAMED NOOR DA, DAUD NAA, ISAH HK, AL-SHAMI HA. Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study. J Pharm Policy Pract. 2022 May 25;15(1):39.
13. AL HEMYARI, S.S., MOHAMED NOOR, D.A. & EL DAHIYAT, F. Attitude and perception of pharmacists and healthcare professionals about the criteria used in drug formulary selection in the United Arab Emirates. J of Pharm Policy and Pract 15, 67 (2022).

1. FAR354: Pharmacoinformatics: Theory and Application
2. FAR344: Central Nervous System and Therapy
3. FAR465: Pharmacy Aseptic Services
4. FAR468: Applied Therapeutics II
5. FEL479: Precision Medicine
6. FCP555: Pharmacotherapeutics IV
7. FCP564: Paediatric Clerkship